Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 152 recruiting now full pipeline #8 of 28,707 conditions

Hypertension: full-pipeline trial registry

152 of 472 indexed Hypertension trials are currently recruiting.

Corpus placement: #8 of 28,707 conditions by registered trial count.

472 US clinical trials · 152 currently recruiting · #8 of 28,707 conditions by registered trial count

Hypertension: 472 US clinical trials tracked, 152 recruiting.

Hypertension is the subject of 472 registered US clinical trials on ClinicalTrials.gov, 152 of them currently open to new participants. 65 are in Phase 3-4 (later-stage) and 64 in Phase 1-2 (earlier-stage). The most active sponsor is Johns Hopkins University, running 15 of these trials.

Enrollment posture brief

Registry condition hypertension

OPEN 152 | RECR 32% | LATE 65 | EARLY 64 | RANK #8 | SPON 15

Nearest open-share peer: Leukemia, Myeloid, Acute (32% recruiting · 31 trials)

Stroke47.8%Non-Small Cell Lung Cancer45.3%Multiple Myeloma37.9%Lung Cancer34%Hypertension (this)32%
Open-enrollment share among volume-matched conditions near Hypertension

Hypertension lists 152 open slots (32% of 472 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hypertension on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hypertension is recruiting below its size-band peers.

    152 of 472 indexed trials (32.2%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Hypertension trials is spread across many organizations.

    Johns Hopkins University accounts for 15 of 472 trials (3.2%). 195 distinct sponsors appear on at least one study for this condition label.

  3. Typical Hypertension enrolment sits around 168 participants.

    Median target enrolment is 168 among the 471 trials that report a genuine target (sentinel values excluded). 170 of those (36.1%) plan for fewer than 100 participants.

  4. Hypertension research is mostly interventional.

    407 interventional and 65 observational studies make up this index (86.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 139Phase 225Phase 337Phase 428

Open and recent trials

472 total, page 4 of 10

RECRUITING NA 10 participants

Sleep Promotion and Pediatric Hypertension

Children's Hospital of Philadelphia

NCT06642246

RECRUITING Early Phase 1 6 participants

Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1)

Benjamin Viglianti

NCT04532489

ACTIVE NOT RECRUITING NA 25,875 participants

Vitamin D and Omega-3 Hypertension Trial (VITAL Hypertension)

Brigham and Women's Hospital

NCT01653678

ACTIVE NOT RECRUITING NA 23,928 participants

Implementing a Home Blood Pressure Monitoring Program in Primary Care

Columbia University

NCT05885997

ACTIVE NOT RECRUITING NA 12,501 participants

Electronic Alert to Improve Testing For Primary Aldosteronism in Patients With Hypertension

Brigham and Women's Hospital

NCT05925569

ACTIVE NOT RECRUITING 11,737 participants

Bogalusa Heart Study

Tulane University

NCT00005129

ACTIVE NOT RECRUITING 5,888 participants

Cardiovascular Health Study (CHS)

National Heart, Lung, and Blood Institute (NHLBI)

NCT00005133

ACTIVE NOT RECRUITING NA 5,760 participants

Team-Based Home Blood Pressure Monitoring

University of Rochester

NCT05488795

ACTIVE NOT RECRUITING 5,306 participants

The Jackson Heart Study of Cardiovascular Disease Among African Americans

National Heart, Lung, and Blood Institute (NHLBI)

NCT00005485

ACTIVE NOT RECRUITING NA 1,452 participants

Patient Education Video to Reduce OTC NSAIDs

Carilion Clinic

NCT06575205

ACTIVE NOT RECRUITING NA 1,306 participants

Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control in Minimize Cognitive Decline

Tulane University

NCT04797403

ACTIVE NOT RECRUITING NA 1,300 participants

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Medtronic Vascular

NCT05198674

ACTIVE NOT RECRUITING NA 1,280 participants

Community Mobilization for Improved Clean Cookstove Uptake, Household Air Pollution Reduction, and Hypertension Prevention

NYU Langone Health

NCT05048147

ACTIVE NOT RECRUITING Phase 3 1,076 participants

Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension

Mineralys Therapeutics

NCT05968430

ACTIVE NOT RECRUITING NA 1,029 participants

The PIVOT Trial: Project on EHR-Integrated Lifestyle Interventions for Adults Aged Fifty and Older

University of Illinois at Chicago

NCT05654142

ACTIVE NOT RECRUITING NA 1,000 participants

Remote Monitoring and Virtual Collaborative Care For Hypertension Control to Prevent Cognitive Decline Phase II

University of Kansas Medical Center

NCT05138601

ACTIVE NOT RECRUITING NA 1,000 participants

Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT)

Johns Hopkins University

NCT06347484

ACTIVE NOT RECRUITING NA 830 participants

Integration of Hypertension Management Into HIV Care in Nigeria

NYU Langone Health

NCT04704336

ACTIVE NOT RECRUITING NA 725 participants

A Randomized Trial of Behaviorally Designed Gamification and Social Incentives to Increase Physical Activity Among Overweight and Obese Veterans

VA Office of Research and Development

NCT05554601

ACTIVE NOT RECRUITING Phase 2 720 participants

Virtual Diabetes Group Visits Across Health Systems

University of Chicago

NCT06094491

ACTIVE NOT RECRUITING NA 542 participants

Dissemination of the Cardiovascular Risk Service

Korey Kennelty

NCT03660631

ACTIVE NOT RECRUITING NA 540 participants

Multi-ethnic Multi-level Strategies and Behavioral Economics to Eliminate Hypertension Disparities in Los Angeles County

University of California, Los Angeles

NCT06359691

ACTIVE NOT RECRUITING NA 528 participants

Equity in Prevention and Progression of Hypertension by Addressing Barriers to Nutrition and Physical activitY

University of Alabama at Birmingham

NCT05367544

ACTIVE NOT RECRUITING 500 participants

Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)

Marymount University

NCT07180147

ACTIVE NOT RECRUITING NA 483 participants

Skills-Based Educational Strategies for Reduction of Vascular Events in Orange County

University of California, Irvine

NCT05641519

ACTIVE NOT RECRUITING NA 472 participants

Home Blood Pressure Telemonitoring LINKED With Community Health Workers to Improve Blood Pressure

Johns Hopkins University

NCT05180045

ACTIVE NOT RECRUITING NA 395 participants

mGlide RCT: A Clinical Glide Path To Close the Guideline-to-Practice Gap In HTN Management

University of Minnesota

NCT03612271

ACTIVE NOT RECRUITING NA 350 participants

Randomized Clinical Trial to Improve Mobility After Hospitalization

University of Pennsylvania

NCT05736484

ACTIVE NOT RECRUITING NA 330 participants

Linkage, Empowerment, and Access to Prevent Hypertension

Wayne State University

NCT05061108

ACTIVE NOT RECRUITING NA 320 participants

Endothelin Receptor Function and Acute Stress

Augusta University

NCT02116335

ACTIVE NOT RECRUITING NA 313 participants

Onco-primary Care Networking to Support TEAM-based Care

Duke University

NCT04258813

ACTIVE NOT RECRUITING Phase 3 300 participants

TARGET BP I Clinical Trial

Ablative Solutions

NCT02910414

ACTIVE NOT RECRUITING NA 300 participants

CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™

Vascular Dynamics

NCT03179800

ACTIVE NOT RECRUITING Phase 4 300 participants

MR Antagonist and LSD1

Brigham and Women's Hospital

NCT04840342

ACTIVE NOT RECRUITING NA 300 participants

RADIANCE Continued Access Protocol

ReCor Medical

NCT05017935

ACTIVE NOT RECRUITING NA 282 participants

A Study of the ReCor Medical Paradise System in Clinical Hypertension

ReCor Medical

NCT02649426

ACTIVE NOT RECRUITING NA 225 participants

The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

ReCor Medical

NCT03614260

ACTIVE NOT RECRUITING Phase 2 206 participants

A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)

Kardigan

NCT06864104

ACTIVE NOT RECRUITING NA 176 participants

Using mHealth to Improve Adherence and Reduce Blood Pressure in Individuals With Hypertension and Mood Disorders

Case Western Reserve University

NCT04675593

ACTIVE NOT RECRUITING NA 150 participants

Groceries for Black Residents of Boston to Stop Hypertension Among Adults With Treated Hypertension

Beth Israel Deaconess Medical Center

NCT05393232

ACTIVE NOT RECRUITING NA 150 participants

Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension

Beth Israel Deaconess Medical Center

NCT05121337

ACTIVE NOT RECRUITING 150 participants

Hypertension Chronobiome

University of Pennsylvania

NCT03598894

ACTIVE NOT RECRUITING NA 122 participants

Breathing Training for Improving Cardiovascular Health in Older Adults With Sleep Apnea

University of Arizona

NCT04932447

ACTIVE NOT RECRUITING Phase 1 120 participants

Caveolin-1 and Vascular Dysfunction

Brigham and Women's Hospital

NCT01426529

ACTIVE NOT RECRUITING NA 110 participants

HELP-HY: Health Education and sLeep Program in HYpertension

Mayo Clinic

NCT03255746

ACTIVE NOT RECRUITING NA 100 participants

A Study of Cardiovascular Disparities in the Greater Mankato Somali Community to Prevent Hypertension

Mayo Clinic

NCT05873153

ACTIVE NOT RECRUITING NA 93 participants

Peer Comparison Feedback to Providers to Improve Hypertension Control

University of Pennsylvania

NCT05160012

ACTIVE NOT RECRUITING NA 90 participants

Team-based Care to Improve Hypertension

New York University

NCT05413252

ACTIVE NOT RECRUITING NA 90 participants

Stress and Blood Pressure Management for Caregivers

Ohio State University

NCT05734638

ACTIVE NOT RECRUITING 72 participants

Epidural Spinal Cord Stimulation for Hypertension in Patients With Neuropathic Pain

University of Kansas Medical Center

NCT04598035

← Previous Page 4 of 10 Next →

Phase Distribution

PhaseTrial count
Phase 1 39
Phase 2 25
Phase 3 37
Phase 4 28

Named interventions

Most-linked intervention names on Hypertension records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
30 trials
Amlodipine Drug
7 trials
Nebivolol Drug
5 trials
Eplerenone Drug
4 trials
Valsartan Drug
4 trials
Ramipril Drug
4 trials
Usual care Other
4 trials
Saline Drug
4 trials

US sites by state

Facility locations filed on Hypertension trials. A trial with sites in several states counts in each.

California 84 trials
Florida 53 trials
Massachusetts 49 trials
New York 47 trials
Illinois 47 trials
Alabama 43 trials
North Carolina 41 trials
Maryland 40 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hypertension page

472 registered trials, 152 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hypertension condition card totals 472 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.